BUL - Pacer US Cash Cows Growth ETF
| Assets | $3.64M |
| NAV | $36.39 |
| Expense Ratio | 0.60% |
| PE Ratio | 28.47 |
| Beta (5Y) | 1.21 |
| Dividend (ttm) | $0.19 |
| Dividend Yield | 0.52% |
| Ex-Dividend Date | Mar 22, 2021 |
| 1-Year Return | - |
| Trading Day | April 21 |
| Last Price | $36.89 |
| Previous Close | $36.41 |
| Change ($) | 0.48 |
| Change (%) | 1.31% |
| Day's Open | - |
| Day's Range | 36.28 - 36.89 |
| Day's Volume | 336 |
| 52-Week Range | 20.68 - 37.45 |
Fund Description
The investment seeks to track the total return performance, before fees and expenses, of the Pacer US Cash Cows Growth Index. The index uses an objective, rules-based methodology to provide exposure to mid- and large-capitalization U.S. companies with high free cash flow yields. Under normal circumstances, at least 80% of the fund's total assets (exclusive of collateral held from securities lending) will be invested in the component securities of the index. It is non-diversified.
| Asset Class Equity | Inception Date May 2, 2019 |
| Exchange NYSEARCA | Ticker Symbol BUL |
| Index Tracked Pacer US Cash Cows Growth Index | |
Top 10 Holdings
48.89% of assets| Name | Symbol | Weight |
|---|---|---|
| Applied Materials | AMAT | 5.73% |
| KLA Corporation | KLAC | 5.57% |
| eBay Inc. | EBAY | 5.21% |
| Qualcomm | QCOM | 5.00% |
| Apple | AAPL | 4.97% |
| Thermo Fisher Scientific | TMO | 4.82% |
| Regeneron Pharmaceuticals | REGN | 4.77% |
| Xilinx | XLNX | 4.70% |
| Vertex Pharmaceuticals | VRTX | 4.67% |
| Arista Networks | ANET | 3.44% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 22, 2021 | $0.023 | Mar 26, 2021 |
| Dec 21, 2020 | $0.023 | Dec 28, 2020 |
| Sep 21, 2020 | $0.075 | Sep 25, 2020 |
| Jun 22, 2020 | $0.068 | Jun 26, 2020 |
| Mar 23, 2020 | $0.061 | Mar 27, 2020 |
| Dec 24, 2019 | $0.078 | Dec 27, 2019 |
Targeted exchange traded fund strategies centered around free cash flow yield can help solidify your portfolio in today's strenuous investing landscape. In the recent webcast, Are Value Managers Measuri...
Value investing is an important part of a diversified portfolio. However, value's underperformance has made it quite difficult to own.
In a growing ETF space, innovation is a key factor to differentiate yourself from the masses, and Pacer ETFs has been doing just that as evidenced in 2019. Investor demand helped Pacer accumulate $2.4 b...